Neuralink Announces Permission to Conduct First Human Experiment
SOPA Images Limited/Alamy
Brain-computer interface company Neuralink announced May 25 that it has received approval from the U.S. Food and Drug Administration (FDA) for clinical studies in humans.
Neuralink made announcement on twitter: “We are pleased to share that we have received FDA approval to initiate a first-in-human clinical study.” It represents an important first step in doing so,” he said.
The company also said the trial has not yet started recruiting and has yet to provide details on what the trial will include.
What is Neuralink?
Neuralink was founded by Elon Musk and a group of scientists and engineers with the ultimate goal of creating a device that interfaces with the human brain, not only reading information from neurons, but also sending information directly back to the brain. Founded in 2016 by So far, the company has had mixed success.
In 2020, Musk unveiled a prototype of Neuralink’s brain-computer interface for the first time in public. The prototype was shaped like a coin, with a wire attached to one side. The circular part is embedded in the skull and the wire is inserted a few millimeters into the surface of the brain.
As part of that announcement, the Neuralink team showed pigs implanted with a device to monitor neurons in their noses that emit signals when the animal touches food or the ground with its nose. They also showed a pig in which the device was safely implanted and then removed. . A year later, the company showed how monkeys could play classic video games. pon using that device. The company was criticized after reports of the deaths of some of the monkeys involved in the experiment and the mistreatment of others.
Similar devices that detect and process brain signals are being used in research laboratories to help paralyzed people walk again, develop mind-controlled wheelchairs, and help people with locked-in syndrome communicate. It has been.
Neuralink did not immediately respond new scientistThis is a comment request from Mr.
topic:
